Ronald Cooper
Chief Executive Officer bij ALBIREO PHARMA, INC.
Vermogen: 38 665 $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jan Peter Mattsson | M | 60 |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom.
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 21 jaar |
| Mike Gutch | M | 58 |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom.
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 9 jaar |
| Christopher Boerner | M | 53 | 9 jaar | |
| Phil Holzer | M | 48 | 11 jaar | |
| David Chiswell | M | 70 |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom.
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 17 jaar |
| Davey Scoon | M | 78 |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 11 jaar |
| Roger Jeffs | M | 62 |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 6 jaar |
| Jason Rhodes | M | 54 | 8 jaar | |
| Anne Klibanski | M | 73 |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 5 jaar |
| Cameron McDonough | M | 53 | 7 jaar | |
| Antoinette Paone | F | 46 | 6 jaar | |
| Alan Sokaler | M | - | - | |
| Yalonda Howze | F | 52 | 1 jaar | |
| Maren Killackey | F | - | - | |
| Catherine Stehman-Breen | M | 61 | 7 jaar | |
| Donald Nicholson | M | 67 | 7 jaar | |
| Louis Schmukler | M | - | 13 jaar | |
| Jeff Jonas | M | 71 | 6 jaar | |
| Matthew Norkunas | M | 46 | 4 jaar | |
| Anthony Quinn | M | 62 | 7 jaar | |
| Gerald Storch | M | 67 | 12 jaar | |
| Gustav Christensen | M | 76 | 7 jaar | |
| Per-Göran Gillberg | M | 68 |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 26 jaar |
| Charles Rowland | M | 65 | 6 jaar | |
| Heather White | F | - | 1 jaar | |
| Paul Streck | M | 60 | 2 jaar | |
| François-Maurice Garnier | M | 62 | 1 jaar | |
| Girish Aakalu | M | - | 6 jaar | |
| Michelle Graham | F | 57 | 5 jaar | |
| Matthew Stanton | M | 51 | 7 jaar | |
| Aymeric Le Chatelier | M | 55 | 1 jaar | |
| Colleen Alabiso | F | - | - | |
| Muffy Carter | F | 71 | 8 jaar | |
| Joan Connolly | F | - | 3 jaar | |
| Dannielle Appelhans | F | 41 | 2 jaar | |
| Zack Newman | M | - | 11 jaar | |
| Christelle Huguet | M | 57 | 1 jaar | |
| Phillip Samayoa | M | 37 | 6 jaar | |
| Jennifer Benenson | F | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Thomas A. Shea | M | 64 |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | - |
| James Cornelius | M | 81 | 10 jaar | |
| Kevin Bitterman | M | 47 | 11 jaar | |
| John E. Celentano | M | 64 | 31 jaar | |
| Jonathan Michael Poole | M | 49 | 4 jaar | |
| Thomas Lynch | M | 63 | 5 jaar | |
| Michael Alfieri | M | 59 | - | |
| Jason Haddock | M | 54 | 14 jaar | |
| Habib Dable | M | 54 | 1 jaar | |
| Carl Decicco | M | 62 | 10 jaar | |
| Kristina Torfgård | M | 61 | 2 jaar | |
| Howard Mayer | M | 62 | 3 jaar | |
| Stephanie Okey | F | 64 | 5 jaar | |
| Jason G. Duncan | M | 50 | - | |
| Douglas Kerr | M | 57 | 5 jaar | |
| Togo Dennis West | M | 81 | 10 jaar | |
| Ali Behbahani | M | 47 | 4 jaar | |
| Sara Den Besten | F | - | - | |
| Simon Harford | M | 64 | - | |
| Jacquelyn Sumer | F | 46 | - | |
| Brian Daniels | M | 65 | 14 jaar | |
| Julia Brown | F | 76 | 2 jaar | |
| Susan Alesina | F | 61 | 1 jaar | |
| Peter A. Zorn | M | 53 | 3 jaar | |
| Alan J. Lacy | M | 70 | 12 jaar | |
| Louis J. Freeh | M | 74 | 8 jaar | |
| Heather Elizabeth Preston | M | 58 | 10 jaar | |
| Anthony Hooper | M | 69 | 15 jaar | |
| Charles Sigal | M | 72 | 16 jaar | |
| Béatrice J. Cazala | F | 67 | 32 jaar | |
| Dinesh C. Paliwal | M | 67 | 8 jaar | |
| James Robinson | M | 88 | 29 jaar | |
| Gisela Schwab | M | 67 | 1 jaar | |
| Leif Valdemar Johansson | M | 73 | 13 jaar | |
| Stephen J. Hoffman | M | 70 | 7 jaar | |
| Denise Scots-Knight | M | 64 | 9 jaar | |
| Robert Williams | M | 75 | 7 jaar | |
| Rebecca Drain | F | 61 | 3 jaar | |
| Lynn Sadowski Mason | F | 45 | 2 jaar | |
| Stephen E. Bear | M | 73 | 7 jaar | |
| John Shamsey | M | - | 6 jaar | |
| Kevin Trapp | M | - | 2 jaar | |
| Wendy Dixon | M | 68 | 8 jaar | |
| Edward Berg | M | - | 2 jaar | |
| Edward Atkinson | M | 58 | 8 jaar | |
| Karen Murphy Santiago | F | 53 | 10 jaar | |
| Xiaolin Liu | M | - | 2 jaar | |
| Randall Owen | M | - | 6 jaar | |
| Freda Lewis-Hall | M | 69 | 5 jaar | |
| Elliott Levy | M | 64 | 17 jaar | |
| Ann Powell | F | 58 | 10 jaar | |
| Kyu-Sung Lee | M | 64 | 5 jaar | |
| Lynn H. Clark | F | 66 | 8 jaar | |
| Cheryl Capps | F | 62 | 13 jaar | |
| Robert G. Petit | M | 64 | 5 jaar | |
| Michael Burgess | M | 61 | - | |
| Mark F. Altmeyer | M | 63 | 2 jaar | |
| Kelly Schick | F | 44 | - | |
| Frances K. Heller | F | 57 | - | |
| David Ian Johnson | M | 66 | 12 jaar | |
| Katrin Rupalla | M | 56 | 7 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 99 | 99.00% |
| Zweden | 7 | 7.00% |
| Verenigd Koninkrijk | 4 | 4.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Ronald Cooper
- Persoonlijk netwerk
